Adriaan Rudolf Liefveld’s Post

View profile for Adriaan Rudolf Liefveld, graphic

Advisory Board Member at Link2Trials and member BEAMER project team

Non-adherence to treatment is an important issue with devastating effects on our society. This is why at Link2Trials we have developed ARM, a personalized patient support solution targeting improved adherence behavior already during clinical studies. Today we are actively involved in BEAMER and have joined forces with Astellas Pharma, Johnson & Johnson Innovative Medicine, Merck Group, Novo Nordisk, Pfizer, Servier, Takeda, and numerous academic organizations and patient organizations to find an innovative and pragmatic approach to finally resolve this issue. Keep an eye out for this amazing team, because in the next 2,5 years we will provide you with the insights and pragmatic approaches you have always been looking for! #beamerproject #patientadherence #patientengagement #clinicalcare #clinicaloperations #healthcareinnovations #patientoutcomes #healtheconomics #healthcareprofessionals #healthinsurancepolicy #regulators

View organization page for Link2Trials, graphic

1,257 followers

For most of us summer vacation is starting. A perfect opportunity to read up on a few interesting articles you may have missed!   Read this article to learn about the BEAMER project and how it will deliver a behavioral science based model that can be integrated in the healthcare chain to enhance adherence to treatment and keep healthcare affordable for all of us. https://lnkd.in/ezMavure Don’t keep this info to yourself. Like and share with your network! #beamerproject #patientadherence #patientengagement #clinicalcare #clinicaloperations #healthcareinnovations #patientoutcomes #healtheconomics #healthcareprofessionals #healthinsurancepolicy #regulators

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics